NCT03137680

Brief Summary

To investigate the effect of pre-operative exercise on

  1. 1.Hemodynamics in the fistula artery and vein, pre and post AV fistula formation
  2. 2.Suitability of cannulation of AV fistula at 8weeks

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 3, 2017

Completed
12 days until next milestone

Study Start

First participant enrolled

May 15, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

May 3, 2017

Status Verified

April 1, 2017

Enrollment Period

1.6 years

First QC Date

April 28, 2017

Last Update Submit

April 28, 2017

Conditions

Keywords

Arteriovenous FistulaPre-operative ExerciseFistula Maturation

Outcome Measures

Primary Outcomes (1)

  • Hemodynamics in the fistula artery and vein, pre and post AV fistula formation

    AV fistula vein diameter, arterial diameter and blood flow rate will be assessed and compared

    22 weeks

Secondary Outcomes (2)

  • Suitability of cannulation of AV fistula

    8 Weeks

  • Secondary fistula failure

    1 year

Study Arms (2)

Control Arm

NO INTERVENTION

No specific exercise regime for the control group. Usual hospital SOP will be adhered to

Exercise Arm

EXPERIMENTAL

The exercise protocol for the intervention group will be to squeeze a soft ball 10 times for set and perform 3 sets of 10 squeezes each at an 1 minute interval. Three sets of exercises to be performed twice in the morning and twice in the evening, for a total of 6 weeks. This will be performed at least 6 weeks prior to the creation of the AV fistula

Behavioral: Hand Exercise

Interventions

Hand ExerciseBEHAVIORAL

Exercise protocol for the intervention group will be to squeeze a soft ball 10 times for set and perform 3 sets of 10 squeezes each at an 1 minute interval. Three sets of exercises to be performed twice in the morning and twice in the evening, for a total of six weeks.

Exercise Arm

Eligibility Criteria

Age21 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic Kidney failure patients with eGFR less than 20mls/min
  • Chosen Hemodailysis as their modality of renal replacement therapy

You may not qualify if:

  • Potential fistula vein diameter less than 3mm (with application of tornique) on initial vein mapping
  • Known left ventricular ejection fraction of less than 20% on Echocardiogram
  • Previous stroke effecting the AV fistula arm
  • Calcified brachial or radial arteries and/or duplex evidence of stenosis of \>50%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Nantakool S, Reanpang T, Prasannarong M, Pongtam S, Rerkasem K. Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access. Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013327. doi: 10.1002/14651858.CD013327.pub2.

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Care Provider i.e., vascular surgeon are blinded to subject randomisation
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

April 28, 2017

First Posted

May 3, 2017

Study Start

May 15, 2017

Primary Completion

December 15, 2018

Study Completion

March 20, 2019

Last Updated

May 3, 2017

Record last verified: 2017-04